Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Learn more about:
Related Access Program
Related Clinical Trial
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies
Study of Proteus Syndrome and Related Congenital Disorders
A Multi-Cohort Phase 2 Dose-Escalation Study of ARQ 092 (Miransertib) in Proteus Syndrome
Dose Finding Trial of ARQ 092 in Children and Adults With Proteus Syndrome